Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Pb.S |
| Molecular Weight | 241.3 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[S--].[PbH2++]
InChI
InChIKey=DDCACOMLHWHRLN-UHFFFAOYSA-N
InChI=1S/Pb.S.2H/q+2;-2;;
| Molecular Formula | HS |
| Molecular Weight | 33.073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Pb |
| Molecular Weight | 209.2 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20340530 | https://www.ncbi.nlm.nih.gov/pubmed/18935555https://www.ncbi.nlm.nih.gov/pubmed/14038324http://nj.gov/health/eoh/rtkweb/documents/fs/1107.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/27486358FRITZ BISCHOFF, L. C. MAXWELL, RICHARD D. EVANS, and FRANKLIN R. NUZUM. Journal of Pharmacology and Experimental Therapeutics September 1928, 34 (1) 85-109, retrived from http://jpet.aspetjournals.org/content/34/1/85 | https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/2535340Curator's Comment: description was created based on several sources, including
https://ntp.niehs.nih.gov/ntp/newhomeroc/roc11/lead-public_508.pdf
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20340530 | https://www.ncbi.nlm.nih.gov/pubmed/18935555https://www.ncbi.nlm.nih.gov/pubmed/14038324http://nj.gov/health/eoh/rtkweb/documents/fs/1107.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/27486358FRITZ BISCHOFF, L. C. MAXWELL, RICHARD D. EVANS, and FRANKLIN R. NUZUM. Journal of Pharmacology and Experimental Therapeutics September 1928, 34 (1) 85-109, retrived from http://jpet.aspetjournals.org/content/34/1/85 | https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/2535340
Curator's Comment: description was created based on several sources, including
https://ntp.niehs.nih.gov/ntp/newhomeroc/roc11/lead-public_508.pdf
There is no information related to biological or pharmacological application of lead(II) bromide (a combustion product of the gasoline additives lead (IV) tetraethyl and 1,2-dibromoethane). It is only known, that this substance possesses mutagenicity.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Highly luminescent nanoscale quasi-2D layered lead bromide perovskites with tunable emissions. | 2016-03-11 |
|
| Rat Testis Damage Caused by Lead Sulfide Nanoparticles After Oral Exposure. | 2016-03 |
|
| Autophagy plays a protective role in cell death of osteoblasts exposure to lead chloride. | 2015-12-03 |
|
| Probit analysis of comparative assays on toxicities of lead chloride and lead acetate to in vitro cultured human umbilical cord blood lymphocytes. | 2015-03 |
|
| The oxidative damage and inflammatory response induced by lead sulfide nanoparticles in rat lung. | 2013-10 |
|
| Maternal low-level lead exposure reduces the expression of PSA-NCAM and the activity of sialyltransferase in the hippocampi of neonatal rat pups. | 2008-07 |
|
| [Lead in the blood and protoporphyrin levels in erythrocytes in glass workers exposed to lead]. | 1997-12 |
|
| Structural Chemistry of Poly(ethylene glycol) Complexes of Lead(II) Nitrate and Lead(II) Bromide. | 1996-11-20 |
|
| [The late effects of exposure to lead fluoride]. | 1992-03 |
|
| Mutagenic effects of lead (II) bromide. | 1989-12 |
|
| Lead oxide emissions--a case history. | 1986 |
|
| Interconnection of activation volumes and activation enthalpies in cubic lead fluoride doped with alkali-metal cations. | 1985-06-15 |
|
| Abiotic factors affecting the toxicity of lead to fungi. | 1979-09 |
|
| Subacute effects of lead-oxide fumes in demolition workers. | 1977-01-08 |
|
| Interaction of lead and bacterial lipids. | 1975-05 |
|
| Microbial uptake of lead. | 1972-06-23 |
|
| [Contribution to the study on allergy among workers exposed to lead oxide and lead sulfide]. | 1961-07-01 |
|
| The effect of topical applications of lead fluoride on dental caries. | 1947-12 |
|
| The effect of topically applied fluorides on dental caries experience; report of findings with two, four and six applications of sodium fluoride and of lead fluoride. | 1947-10-10 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20340530
Unknown
Route of Administration:
Dental
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:53:02 GMT 2025
by
admin
on
Mon Mar 31 18:53:02 GMT 2025
|
| Record UNII |
2425D15SYM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
215-246-6
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | |||
|
2425D15SYM
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | |||
|
C018391
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | |||
|
1314-87-0
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | |||
|
DTXSID0025498
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | |||
|
m6746
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | Merck Index | ||
|
LEAD(II) SULFIDE
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | |||
|
300000024312
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | |||
|
2425D15SYM
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | |||
|
639
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | |||
|
1549104
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY | RxNorm | ||
|
9794739
Created by
admin on Mon Mar 31 18:53:02 GMT 2025 , Edited by admin on Mon Mar 31 18:53:02 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |